CHRISTINE KELADES: Open Payments
NPI 1407104037 · HUDSON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,611 in 177 payments from 23 companies in 2025. Trend: 2023 $462 · 2024 $2,655 · 2025 $3,611
Food & beverage: $3,611
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 74 | $1,482 |
| Janssen Biotech, Inc. | 15 | $240 |
| Phathom Pharmaceuticals, Inc. | 9 | $237 |
| QOL Medical, LLC | 11 | $223 |
| Ardelyx, Inc. | 16 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $210 |
| Novo Nordisk Inc | 4 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $120 |
| PFIZER INC. | 5 | $91 |
| Lilly USA, LLC | 4 | $72 |
Products named: RINVOQ, SKYRIZI, CREON, TREMFYA, VOQUEZNA, Sucraid, IBSRELA, Wegovy.
Industry payments across OH — which companies pay providers there.
